Type 1 diabetes is an autoimmune disease that destroys insulin-producing cells in the pancreas. Learn how it differs from type 2, why early detection matters, and what new treatments like teplizumab and stem cell therapy are changing the game.
When your immune system mistakenly attacks the insulin-making cells in your pancreas, you develop autoimmune diabetes, a chronic condition where the body can’t produce enough insulin to regulate blood sugar. Also known as type 1 diabetes, it’s not caused by diet or lifestyle—it’s an internal error in how your body identifies its own cells. Unlike type 2 diabetes, which often develops slowly with insulin resistance, autoimmune diabetes strikes suddenly and requires lifelong insulin use. People with this condition don’t just need to monitor their blood sugar—they need to understand how other medications, like SGLT2 inhibitors, a class of drugs that help the kidneys remove excess glucose, can interact with their treatment. These drugs, while helpful for type 2 diabetes, carry risks like euglycemic diabetic ketoacidosis even when blood sugar looks normal.
Managing autoimmune diabetes isn’t just about insulin shots. It’s about balancing food, activity, stress, and other meds. That’s why tools like DPP-4 inhibitors, medications that boost the body’s natural insulin response are sometimes added, especially in mixed cases where type 1 and type 2 features overlap. Saxagliptin, for example, is used in some patients with autoimmune diabetes who still have some insulin-producing capacity. It doesn’t replace insulin but helps smooth out spikes without causing low blood sugar. Meanwhile, people with autoimmune diabetes often face kidney complications, making renal diet tips and sodium control just as important as insulin timing. The same people who need to watch their potassium and phosphorus intake for kidney health might also be on medications like metformin or newer agents that affect how the body handles glucose.
There’s no cure yet, but better tools are making life easier. Understanding how insulin interacts with other drugs—like beta blockers for anxiety or diuretics for fluid retention—can prevent dangerous side effects. If you’re living with autoimmune diabetes, you’re not just managing a number on a meter. You’re learning how your body responds to food, exercise, stress, and medication over time. The posts below cover real-world strategies, from how SGLT2 inhibitors can backfire if not monitored, to how DPP-4 inhibitors fit into complex treatment plans, and why knowing your insulin needs changes as you age or develop other conditions. You’ll find practical advice, not theory—what works, what doesn’t, and what to ask your doctor next.
Type 1 diabetes is an autoimmune disease that destroys insulin-producing cells in the pancreas. Learn how it differs from type 2, why early detection matters, and what new treatments like teplizumab and stem cell therapy are changing the game.